HIA
NVO

Harbor Investment Advisory’s Novo Nordisk NVO Stock Holding History

Harbor Investment Advisory’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Buy
8,678
+185
+2% +$7.95K 0.03% 321
2026
Q1 		$312K Buy
8,493
+837
+11% +$39.7K 0.02% 342
2025
Q4 		$390K Buy
7,656
+4,003
+110% +$205K 0.03% 315
2025
Q3 		$203K Buy
3,653
+220
+6% +$12.9K 0.02% 394
2025
Q2 		$237K Buy
3,433
+1,059
+45% +$72K 0.02% 346
2025
Q1 		$165K Buy
2,374
+574
+32% +$47.4K 0.02% 393
2024
Q4 		$155K Buy
1,800
+153
+9% +$16.5K 0.01% 384
2024
Q3 		$196K Sell
1,647
-247
-13% -$32.9K 0.02% 344
2024
Q2 		$270K Buy
1,894
+36
+2% +$4.77K 0.03% 298
2024
Q1 		$239K Buy
1,858
+977
+111% +$116K 0.02% 315
2023
Q4 		$91.1K Buy
881
+653
+286% +$64.6K 0.01% 438
2023
Q3 		$20.7K Buy
228
+20
+10% +$1.76K ﹤0.01% 687
2023
Q2 		$16.8K Buy
208
+4
+2% +$327 ﹤0.01% 923
2023
Q1 		$16.2K Hold
204
– – ﹤0.01% 946
2022
Q4 		$13.8K Buy
204
+8
+4% +$469 ﹤0.01% 969
2022
Q3 		$10K Buy
196
+8
+4% +$429 ﹤0.01% 1042
2022
Q2 		$10K Sell
188
-340
-64% -$18.9K ﹤0.01% 1035
2022
Q1 		$29K Hold
528
– – ﹤0.01% 872
2021
Q4 		$30K Hold
528
– – ﹤0.01% 867
2021
Q3 		$25K Hold
528
– – ﹤0.01% 914
2021
Q2 		$22K Hold
528
– – ﹤0.01% 886
2021
Q1 		$18K Hold
528
– – ﹤0.01% 893
2020
Q4 		$18K Hold
528
– – ﹤0.01% 843
2020
Q3 		$18K Hold
528
– – ﹤0.01% 762
2020
Q2 		$17K Buy
528
+386
+272% +$12.3K ﹤0.01% 678
2020
Q1 		$4K Hold
142
– – ﹤0.01% 877
2019
Q4 		$4K Buy
+142
New +$3.93K ﹤0.01% 733

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Harbor Investment Advisory's NVO Position: Q2 2026 in Review

Harbor Investment Advisory increased its Novo Nordisk (NVO) stake by 2.2% in Q2 2026, buying an estimated $7.95K and bringing the position to 8,678 shares worth $416K. The position accounts for 0.03% of the portfolio, ranked #321.

Harbor Investment Advisory first reported a position in NVO in Q4 2019 and has held it in 27 quarters since. 433 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Harbor Investment Advisory held 8,678 shares of Novo Nordisk worth $416K as of Q2 2026.
  • Harbor Investment Advisory bought 185 Novo Nordisk shares in Q2 2026, an estimated $7.95K.
  • Novo Nordisk made up 0.03% of Harbor Investment Advisory's portfolio in Q2 2026, its #321 holding.
  • Harbor Investment Advisory first reported a position in Novo Nordisk in Q4 2019 and has held it in 27 quarters since.
  • 433 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.